insights_auto
Kwa nini AGIO imepungua kwa 3.10%?
Fahamu zaidichevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ 28.76
arrow_downward
-3.10%(-0.92) Siku 1
US$ 28.76
0.00% (0.00)
bedtimeBaada ya saa
Imefungwa: 19 Nov, 16:00:01 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AGIO...
Fungua
US$ 29.93
Juu
US$ 30.35
Chini
US$ 28.71
Mtaji wa soko
1.72B
Wastani wa kiasi cha mauzo
1.18M
Kiasi cha mauzo ya hisa
elfu 590.44
Juu kwa wiki 52
US$ 44.07
Chini kwa wiki 52
US$ 23.02
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Fungua
US$ 29.93
Juu
US$ 30.35
Chini
US$ 28.71
Mtaji wa soko
1.72B
Wastani wa kiasi cha mauzo
1.18M
Kiasi cha mauzo ya hisa
elfu 590.44
Juu kwa wiki 52
US$ 44.07
Chini kwa wiki 52
US$ 23.02
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
FOREX.com
·
saa 6 zilizopita
S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
FXStreet
·
saa 7 zilizopita
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Traders Union
·
saa 7 zilizopita
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
BigGo Finance
·
saa 4 zilizopita
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
Wasifu
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Kuhusu Agios Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi540
Lilianzishwa2008
Makao makuu-
SektaHealth Care
Sekta-
Tovutiagios.com